Isoflurane, 0.5 Minimum Alveolar Concentration Administered Through the Precardiopulmonary Bypass Period, Reduces Postoperative Dobutamine Requirements of Cardiac Surgery Patients: A Randomized Study

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 21, Issue 5, 2007, Pages 683-689

  Ndoko, Serge K ^a   Tual, Loïc ^a   Ait Mamar, Bouziane ^a   Sauvat, Stéphane ^a   Jabre, Patricia ^a   Zakhouri, Mohamed ^a   Rosanval, Odile ^a   Abdi, Moustapha ^a   Kirsch, Matthias ^a   Pouzet, Bruno ^a   Loisance, Daniel ^a   Dhonneur, Gilles ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

cardiac surgery; cardiopulmonary bypass; dobutamine; isoflurane; preconditioning

Indexed keywords

ATRACURIUM; DOBUTAMINE; ISOFLURANE; PROPOFOL; SUFENTANIL; TROPONIN I;

AGED; ANESTHESIA INDUCTION; ARTICLE; BODY WEIGHT; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HEART FUNCTION; HEART HEMODYNAMICS; HEART PROTECTION; HEART SURGERY; HUMAN; INTRAVENOUS ANESTHESIA; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-AGONISTS; AGED; ALGORITHMS; ANESTHETICS, INHALATION; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; DOBUTAMINE; FEMALE; HUMANS; ISOFLURANE; LENGTH OF STAY; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; TROPONIN I;

EID: 34748870815     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2006.12.015     Document Type: Article

References (33)

1. Kloner R., and Jennings R. Consequences of brief ischemia: Stunning, preconditioning, and their clinical implications: Part 1. Circulation 104 (2001) 2981-2989
2. Kloner R., and Jennings R. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: Part 2. Circulation 104 (2001) 3158-3167
3. ATP channels via multiple signaling pathways. Anesthesiology 97 (2002) 4-14
4. Zaugg M., Lucchinetti E., Spahn D.R., et al. Differential effects of anesthetics on mitochondrial KATP channel activity and cardiomyocyte protection. Anesthesiology 97 (2002) 15-23
5. Cason B.A., Gamperl A.K., Slocum R.E., et al. Anesthetic-induced preconditioning. Previous administration of isoflurane decrease myocardial infarct size in rabbits. Anesthesiology 87 (1997) 1182-1190
6. Tanaka K., Weihrauch D., Ludwig L.M., et al. Mitochondrial adenosine triphosphate-regulated potassium channel opening acts as a trigger for isoflurane-induced preconditioning by generating reactive oxygen species. Anesthesiology 98 (2003) 935-943
7. Lucchinetti E., da Silva R., Pasch T., et al. Anesthetic preconditioning but not postconditioning prevents early activation of the deleterious cardiac remodelling programme: Evidence of opposing genomic responses in cardioprotection by pre- and postconditioning. Br J Anaesth 95 (2005) 140-152
8. Sergeev P., da Silva R., Lucchinetti E., et al. Trigger-dependent gene expression profiles in cardiac preconditioning. Evidence for distinct genetic programs in ischemic and anesthetic preconditioning. Anesthesiology 100 (2004) 474-488
9. Haroun-Bizri S., Khoury S.S., Chebab I.R., et al. Does isoflurane optimize myocardial protection during cardiopulmonary bypass?. J Cardiothorac Vasc Anesth 15 (2001) 418-421
10. Tomai F., De Paulis R., Penta de Peppo A., et al. Beneficial impact of isoflurane during coronary bypass surgery on troponin I release. G Ital Cardiol 29 (1999) 1007-1014
11. Penta de Peppo A., Polisca P., Tomai F., et al. Recovery of LV contractility in man is enhanced by preischemic administration of enflurane. Ann Thorac Surg 68 (1999) 112-118
12. Belhomme D., Peynet J., Louzy M., et al. Evidence for preconditioning in coronary artery bypass graft surgery. Circulation 100 suppl II (1999) II-340-II-344
13. Julier K., da Silva R., Garcia C., et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: A double-blinded, placebo-controlled, multicenter study. Anesthesiology 98 (2003) 1315-1327
14. De Hert S.G., ten Broecke P.W., Mertens E., et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 97 (2002) 42-49
15. De Hert S.G., Cromheecke S., ten Broecke P.W., et al. Effect of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology 99 (2003) 314-323
16. De Hert S.G., Van der Linden P.J., Cromheecke S., et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 101 (2004) 299-310
17. De Hert S.G., Van der Linden P.J., Cromheecke S., et al. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 101 (2004) 9-20
18. Cromheecke S., Pepermans V., Hendrickx E., et al. Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass. Anesth Analg 103 (2006) 289-296
19. Guarracino F., Landoni G., Tritapepe L., et al. Myocardial damage prevented by volatile anesthetics: A multicenter randomized controlled study. J Cardiothorac Vasc Anesth 20 (2006) 477-483
20. Moher D., Schulz K.F., and Altman D.G. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 (2001) 1191-1194
21. Nader N.D., Li C.M., Khadra W.Z., et al. Anesthetic myocardial protection with sevoflurane. J Cardiothorac Vasc Anesth 18 (2004) 269-274
22. Nader N.D., Karamanoukian H.L., Reedy R.L., et al. Inclusion of sevoflurane in cardioplegia reduces neutrophil activity during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 20 (2006) 57-62
23. Kawamura T., Kadosaki M., Nara N., et al. Effects of sevoflurane on cytokine balance in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 20 (2006) 503-508
24. Leung J.M., Bellows W.H., and Pastor D. Does intraoperative evaluation of left ventricular contractile reserve predict myocardial viability?. A clinical study using dobutamine stress echocardiography in patients undergoing coronary artery bypass graft surgery. Anesth Analg 99 (2004) 647-654
25. Nashef S.A., Roques F., Michel P., et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16 (1999) 9-13
26. Rodig G., Wild K., Behr R., et al. Effects of desflurane and isoflurane on systemic vascular resistance during hypothermic cardiopulmonary bypass. J Cardiothorac Vasc Anesth 11 (1997) 54-57
27. Warltier D.C., and Pagel P.S. Cardiovascular and respiratory actions of desflurane: Is desflurane different from isoflurane?. Anesth Analg 75 suppl 4 (1992) S17-S29
28. Kehl F., Krolikowski J.G., Mraovic B., et al. Is isoflurane-induced preconditioning dose related?. Anesthesiology 96 (2002) 675-680
29. Law-Koune J.D., Raynaud C., Liu N., et al. Sevoflurane-remifentanil versus propofol-remifentanil anesthesia at a similar bispectral level for off-pump coronary artery surgery: No evidence of reduced myocardial ischemia. J Cardiothorac Vasc Anesth 20 (2006) 484-492
30. Ismail E.F., Kim S.J., Salem M.R., et al. Direct effects of propofol on myocardial contractility in in situ canine hearts. Anesthesiology 77 (1992) 964-972
31. Gueugniaud P.Y., Hanouz J.L., Martino J.M., et al. Interaction of halogenated anesthetics with dobutamine in rat myocardium. Anesthesiology 90 (1999) 1663-1670
32. Hanouz J.L., Vivien B., Gueugniaud P.Y., et al. Interaction of isoflurane and sevoflurane with alpha- and beta-adrenoceptor stimulations in rat myocardium. Anesthesiology 88 (1998) 1249-1258
33. Davies L.A., Hamilton D.L., Hopkins P.M., et al. Concentration-dependent inotropic effects of halothane, isoflurane and sevoflurane on rat ventricular myocytes. Br J Anaesth 82 (1999) 723-730